# RNA-Loaded Dendritic Cell Cancer Vaccine

> **NCT00087984** · PHASE1,PHASE2 · COMPLETED · sponsor: **Argos Therapeutics** · enrollment: 26 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** MB-002

## Key facts

- **NCT ID:** NCT00087984
- **Lead sponsor:** Argos Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00087984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00087984, "RNA-Loaded Dendritic Cell Cancer Vaccine". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00087984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*